FDA cleared the Minder® System from Epi-Minder Pty, Ltd. on Oct 29, 2026 under K262318, a traditional 510(k). The device falls under product code SEM, Sub-Scalp Implanted Electroencephalogram System For Remote Patient Monitoring, regulated at 21 CFR 882.1360 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on Jul 8, 2026. The decision came 113 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Epi-Minder Pty, Ltd. in the last 12 months of the tracker.